$KITE to Present at the 2015 Barclays Global Healthcare Conference

Biotech Stocks

Kite Pharma to Present at the 2015 Barclays Global Healthcare Conference

Kite Pharma, Inc., (KITE), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT(TM)) products for the treatment of cancer, today announced that David Chang, M.D., Ph.D., Kite’s Executive Vice President, Research and Development, and Chief Medical Officer, will present a company overview at the Barclays Global Healthcare Conference at the Loews Miami Beach Hotel. The presentation will take place on Tuesday March 10, 2015, at 9:30 a.m. EDT.

About Kite Pharma

Kite Pharma, Inc., is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT(TM) designed to restore the immune system’s ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com.

Kite Contacts:
Cynthia M. Butitta
Chief Financial Officer and Chief Operating Officer
(310) 824-9999
For Media: Justin Jackson
For Investor Inquiries: Nancy Yu
Burns McClellan
(212) 213-0006
[email protected]
[email protected]


Please enter your comment!
Please enter your name here